AFT Pharmaceutical's multi-billion R&D opportunity
Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
Market Cap $5.110B
!
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Announcements
Filter Results
| TLX | AGM - Results of Meeting | 19/04/18 | ||
| TLX | Chairman and CEO Address to Shareholders | 19/04/18 | ||
| TLX | Translational Research Partnership with INSERM and ARRONAX | PRICE SENSITIVE | 16/04/18 | |
| TLX | Telix JV Entity Contract with Endocyte for Prostate Imaging | PRICE SENSITIVE | 10/04/18 | |
| TLX | Update - prostate imaging program | PRICE SENSITIVE | 28/03/18 | |
| TLX | Drug Master File for Prostate Imaging Product Filed with FDA | PRICE SENSITIVE | 26/03/18 | |
| TLX | AGM Notice of Meeting and Proxy Form | 15/03/18 | ||
| TLX | Telix and Radboud University Medical Centre Collaboration | PRICE SENSITIVE | 15/03/18 | |
| TLX | Appendix 3B - release of shares from mandatory escrow | 06/03/18 | ||
| TLX | Odile Jaume to lead Telix European Operations | 01/03/18 | ||
| TLX | Corporate Governance Statement | 26/02/18 | ||
| TLX | Appendix 4G - key to governance disclosures | 26/02/18 | ||
| TLX | Appendix 4E and 2017 Annual Report | PRICE SENSITIVE | 26/02/18 | |
| TLX | Shareholder Update | PRICE SENSITIVE | 21/02/18 | |
| TLX AGM - Results of Meeting | |||
| 19/04/18 | |||
| TLX Chairman and CEO Address to Shareholders | |||
| 19/04/18 | |||
| TLX Translational Research Partnership with INSERM and ARRONAX | |||
| 16/04/18 | PRICE SENSITIVE | ||
| TLX Telix JV Entity Contract with Endocyte for Prostate Imaging | |||
| 10/04/18 | PRICE SENSITIVE | ||
| TLX Update - prostate imaging program | |||
| 28/03/18 | PRICE SENSITIVE | ||
| TLX Drug Master File for Prostate Imaging Product Filed with FDA | |||
| 26/03/18 | PRICE SENSITIVE | ||
| TLX AGM Notice of Meeting and Proxy Form | |||
| 15/03/18 | |||
| TLX Telix and Radboud University Medical Centre Collaboration | |||
| 15/03/18 | PRICE SENSITIVE | ||
| TLX Appendix 3B - release of shares from mandatory escrow | |||
| 06/03/18 | |||
| TLX Odile Jaume to lead Telix European Operations | |||
| 01/03/18 | |||
| TLX Corporate Governance Statement | |||
| 26/02/18 | |||
| TLX Appendix 4G - key to governance disclosures | |||
| 26/02/18 | |||
| TLX Appendix 4E and 2017 Annual Report | |||
| 26/02/18 | PRICE SENSITIVE | ||
| TLX Shareholder Update | |||
| 21/02/18 | PRICE SENSITIVE | ||
